August 16, 2025 - 02:05

Shares of PAR Technology experienced a notable increase of 3.6% during the morning trading session, following a positive upgrade from BTIG brokerage. The firm elevated its rating on the company’s stock from 'Neutral' to 'Buy' and established a price target of $65. This optimistic outlook is largely attributed to PAR Technology's robust sales pipeline and its success in securing significant enterprise contracts.
Analyst Andrew Harte emphasized that the company is well-positioned for substantial growth, projecting an annual increase exceeding 15% over the next three years. The strong demand for PAR's restaurant technology solutions, combined with its strategic partnerships and innovative offerings, reinforces the confidence in its future performance. Investors are keenly watching these developments, as the company's ability to capitalize on market opportunities could enhance its competitive edge in the restaurant technology sector. As a result, the stock's upward momentum reflects growing optimism among market participants regarding PAR Technology's potential for sustained growth.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...